is the bell ringing for INRs with this factor X inhibitor?
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial
skip to main |
skip to sidebar
news stories and sundry information relevant to busy physicians and other health care providers interested in long term care.
No comments:
Post a Comment